Ftse Mib
36.191,17
-0,03%
DAX
21.282,18
-0,48%
S&P 500
6.012,28
-1,46%
NASDAQ
19.341,83
-3,07%
Bitcoin
101.474,45
-0,58%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cocrystal Pharma Inc (COCP) Cocrystal Pharma Inc (COCP) Notizie

Cocrystal Pharma Inc

COCP
2,057
-0,0543 (-2,57%)
28 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202514:00EDGAR2Form 8-K - Current report
08/1/202514:30EDGAR2Form 8-K - Current report
08/1/202514:00GLOBECocrystal Pharma Reports Phase 1 Results with Oral,..
31/12/202414:30EDGAR2Form 8-K - Current report
31/12/202414:00GLOBECocrystal Pharma to Extend Phase 2a Influenza Challenge..
13/11/202421:30EDGAR2Form 8-K - Current report
13/11/202414:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202414:00GLOBECocrystal Pharma Reports Third Quarter 2024 Financial..
31/10/202414:10EDGAR2Form 8-K - Current report
31/10/202413:00GLOBECocrystal Pharma’s Co-CEOs Highlight Pioneering Approach to..
11/10/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202423:02EDGAR2Form 8-K - Current report
26/9/202414:00GLOBECocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor..
20/8/202414:00EDGAR2Form 8-K - Current report
19/8/202422:05GLOBECocrystal Pharma to Highlight Near-term Clinical Milestones..
14/8/202414:15EDGAR2Form 8-K - Current report
14/8/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202414:00GLOBECocrystal Pharma Reports Second Quarter 2024 Financial..
18/7/202415:00EDGAR2Form 8-K - Current report
18/7/202414:00GLOBECocrystal Pharma Reports Favorable Results from..
20/6/202414:30EDGAR2Form 8-K - Current report
20/6/202414:00GLOBENew Broad-Spectrum Antiviral Currently in a Phase 2a..
13/5/202414:15EDGAR2Form 8-K - Current report
13/5/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202414:00GLOBECocrystal Pharma Reports First Quarter 2024 Financial..
07/5/202422:30EDGAR2Form DEF 14A - Other definitive proxy statements
01/5/202414:00GLOBEEnrollment Completed in Phase 2a Study with Cocrystal..
28/3/202413:00GLOBECocrystal Pharma Reports 2023 Financial Results and Provides..
19/3/202413:00GLOBECocrystal Pharma Receives Pre-IND Responses from the FDA on..
01/3/202422:15EDGAR2Form 8-K - Current report
Apertura: 2,04 Min: 2,005 Max: 2,12
Chiusura: 2,1113

La tua Cronologia

NASDAQ
COCP
Cocrystal Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network